LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $188,755 | +323.0% | 2,566 | +284.1% | 0.06% | +306.7% |
| Q4 2022 | $44,622 | +346.2% | 668 | +486.0% | 0.02% | +150.0% |
| Q2 2022 | $10,000 | -75.6% | 114 | -68.5% | 0.01% | -71.4% |
| Q1 2022 | $41,000 | -51.2% | 362 | -33.2% | 0.02% | -46.2% |
| Q4 2021 | $84,000 | +68.0% | 542 | +49.7% | 0.04% | +21.9% |
| Q3 2021 | $50,000 | +257.1% | 362 | +232.1% | 0.03% | +255.6% |
| Q2 2021 | $14,000 | – | 109 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |